Delivery Order SPE2DB22D6029-SPE2DB24FU0MM
Award Date 4/4/24
Potential Completion Date 4/25/24
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution services company. The award is for the supply of REVLIMID 15 MG CAPSULE 21S, a specialty pharmaceutical product, at a firm fixed price of $10,526.04. The completion date for this delivery order is February 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $151,045.52 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply REVLIMID 10 MG CAPSULE 100S. This delivery order was issued against an existing indefinite delivery contract with the agency. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization that primarily provides pharmaceutical products and distribution services to U.S....
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,281.49, is for the delivery of REVLIMID 25 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and is a Firm Fixed Price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4564060034 REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $13,929.89 and a performance period through April 12, 2024. This delivery order is issued under Amerisourcebergen's pre-existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $106,869.32 contract is for the supply of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 25, 2022. AmerisourceBergen Drug Corp, a for-profit organization, has received numerous federal contracts to provide pharmaceuticals, medical supplies, and related distribution...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a $10,254 firm fixed price delivery order to AmerisourceBergen Drug Corp for REVLIMID 25 mg capsules (21-count units) on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside award was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...